Business with STENDHAL


Strategic alliances with our Business Partners are key to the success of Stendhal.


We are very proud of our partnerships and our combined commercial success in Latin America. We are interested in selective opportunities to expand our portfolio in CNS, Cardiovascular, Metabolism, Oncology, Genetic Disorders and Infectious Disease across our 14 country territory in Latin America. In addition, Stendhal is an active clinical development partner interested in participating in Phase 3 clinical trials in Latin America.


For more information about potential partnership opportunities, please contact us at